These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9814647)

  • 21. [Enfermedad de Chagas en México].
    Rojo-Medina J; Ruiz-Matus C; Salazar-Schettino PM; González-Roldán JF
    Gac Med Mex; 2018; 154(5):605-612. PubMed ID: 30407465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Why defer blood donor candidates because of an exposure risk to Chagas disease?].
    Garraud O; Pelletier B; Aznar C
    Transfus Clin Biol; 2008 Jun; 15(3):123-8. PubMed ID: 18620885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of Trypanosoma cruzi infection among at-risk blood donors in Japan.
    Sayama Y; Furui Y; Takakura A; Ishinoda M; Matsumoto C; Taira R; Igarashi S; Momose S; Matsubayashi K; Uchida S; Hino S; Nagai T; Satake M
    Transfusion; 2019 Jan; 59(1):287-294. PubMed ID: 30474861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk of Chagas disease through transfusions in the Americans].
    Schmuñis GA
    Medicina (B Aires); 1999; 59 Suppl 2():125-34. PubMed ID: 10668254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of Trypanosoma cruzi in blood donors at the National Blood Transfusion Services--Guyana.
    Bwititi PT; Browne J
    West Indian Med J; 2012 Sep; 61(6):559-63. PubMed ID: 23441347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American trypanosomiasis (Chagas' disease) and blood banking in Mexico City: seroprevalence and its potential transfusional transmission risk.
    Monteón-Padilla VM; Hernández-Becerril N; Guzmán-Bracho C; Rosales-Encina JL; Reyes-López PA
    Arch Med Res; 1999; 30(5):393-8. PubMed ID: 10596460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pragmatic data and observations related to the epidemiology of Chagas disease].
    Schenone H; Rojas A
    Bol Chil Parasitol; 1989; 44(3-4):66-86. PubMed ID: 2518649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfusion transmitted Chagas disease: is it really under control?
    Wendel S
    Acta Trop; 2010; 115(1-2):28-34. PubMed ID: 20044970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chagasic infection in blood donors from hospitals in endemic regions of Chile (1982-1987). Epidemiological impact of the problem].
    Contreras MC; Schenone H; Borgoño JM; Salinas P; Sandoval L; Rojas A; Solís F
    Bol Chil Parasitol; 1992; 47(1-2):10-5. PubMed ID: 1306985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease.
    Rassi A; Dias JC; Marin-Neto JA; Rassi A
    Heart; 2009 Apr; 95(7):524-34. PubMed ID: 19131444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. American Red Cross to screen blood for Chagas' disease.
    McCarthy M
    Lancet; 2003 Dec; 362(9400):1988. PubMed ID: 14686364
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chagas disease and blood transfusion: an emerging issue in non-endemic countries].
    Assal A; Corbi C
    Transfus Clin Biol; 2011 Apr; 18(2):286-91. PubMed ID: 21440479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chagas' disease in Sweden--great need of guidelines for testing. Probably hundreds of seropositive cases, only a few known].
    Sandahl K; Botero-Kleiven S; Hellgren U
    Lakartidningen; 2011 Nov 16-22; 108(46):2368-71. PubMed ID: 22468375
    [No Abstract]   [Full Text] [Related]  

  • 34. The elimination of Chagas' disease from Brazil.
    Massad E
    Epidemiol Infect; 2008 Sep; 136(9):1153-64. PubMed ID: 18053273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors.
    Leiby DA; Read EJ; Lenes BA; Yund AJ; Stumpf RJ; Kirchhoff LV; Dodd RY
    J Infect Dis; 1997 Oct; 176(4):1047-52. PubMed ID: 9333165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina.
    Sánchez Negrette O; Mora MC; Basombrío MA
    Pediatrics; 2005 Jun; 115(6):e668-72. PubMed ID: 15930194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk for transfusion-transmitted infectious diseases in Central and South America.
    Schmunis GA; Zicker F; Pinheiro F; Brandling-Bennett D
    Emerg Infect Dis; 1998; 4(1):5-11. PubMed ID: 9452393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trypanosoma cruzi in a low- to moderate-risk blood donor population: seroprevalence and possible congenital transmission.
    Leiby DA; Fucci MH; Stumpf RJ
    Transfusion; 1999 Mar; 39(3):310-5. PubMed ID: 10204596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negligible prevalence of antibodies against Trypanosoma cruzi among blood donors in the southeastern United States.
    Barrett VJ; Leiby DA; Odom JL; Otani MM; Rowe JD; Roote JT; Cox KF; Brown KR; Hoiles JA; Saez-Alquézar A; Turrens JF
    Am J Clin Pathol; 1997 Nov; 108(5):499-503. PubMed ID: 9353087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfusion-associated Chagas' disease in Texas: report of a case.
    Cimo PL; Luper WE; Scouros MA
    Tex Med; 1993 Dec; 89(12):48-50. PubMed ID: 8178305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.